Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (61-70 of 459) with videos related to

Pageof 46
Sort By:
Gastroenterology Research and Practice|August 8, 2014
Neoadjuvant therapy in pancreatic cancer: an emerging strategyAlessandro Bittoni, Matteo Santoni, Andrea Lanese, et al.
Current Cancer Drug Targets|November 30, 2012
Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma: When is the revolution coming?Matteo Santoni, Mimma Rizzo, Luciano Burattini, et al.
Nature Reviews. Urology|November 22, 2022
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinomaMatteo Rosellini, Andrea Marchetti, Veronica Mollica, et al.
The Journal of Urology|April 28, 2026
From cystectomy to conservation: can perioperative EVP and immuno-RT redefine the standard of care in MIBC?Javier Molina-Cerrillo, Matteo Santoni, Fernando Sabino Marques Monteiro, et al.
Frontiers in Immunology|May 20, 2020
Involvement of the TRPML Mucolipin Channels in Viral Infections and Anti-viral Innate Immune ResponsesGiorgio Santoni, Maria Beatrice Morelli, Consuelo Amantini, et al.
Biomolecules|January 21, 2022
The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib TreatmentGiorgio Santoni, Consuelo Amantini, Federica Maggi, et al.
Frontiers in Immunology|August 2, 2021
Mechanosensation and Mechanotransduction in Natural Killer CellsGiorgio Santoni, Consuelo Amantini, Matteo Santoni, et al.
Advances in Experimental Medicine and Biology|October 25, 2019
Targeting Transient Receptor Potential Channels by MicroRNAs Drives Tumor Development and ProgressionGiorgio Santoni, Maria Beatrice Morelli, Matteo Santoni, et al.
Current Drug Targets|December 4, 2014
Morphologic and molecular backgrounds for personalized management of genito-urinary cancers: an overviewRodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, et al.
Advances in Experimental Medicine and Biology|October 25, 2019
Calcium Signaling and the Regulation of Chemosensitivity in Cancer Cells: Role of the Transient Receptor Potential ChannelsGiorgio Santoni, Maria Beatrice Morelli, Oliviero Marinelli, et al.
Pageof 46

Showing results (61-70 of 459) with videos related to

Sort By:
Pageof 46
Gastroenterology Research and Practice|August 8, 2014
Neoadjuvant therapy in pancreatic cancer: an emerging strategyAlessandro Bittoni, Matteo Santoni, Andrea Lanese, et al.
Current Cancer Drug Targets|November 30, 2012
Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma: When is the revolution coming?Matteo Santoni, Mimma Rizzo, Luciano Burattini, et al.
Nature Reviews. Urology|November 22, 2022
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinomaMatteo Rosellini, Andrea Marchetti, Veronica Mollica, et al.
The Journal of Urology|April 28, 2026
From cystectomy to conservation: can perioperative EVP and immuno-RT redefine the standard of care in MIBC?Javier Molina-Cerrillo, Matteo Santoni, Fernando Sabino Marques Monteiro, et al.
Frontiers in Immunology|May 20, 2020
Involvement of the TRPML Mucolipin Channels in Viral Infections and Anti-viral Innate Immune ResponsesGiorgio Santoni, Maria Beatrice Morelli, Consuelo Amantini, et al.
Biomolecules|January 21, 2022
The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib TreatmentGiorgio Santoni, Consuelo Amantini, Federica Maggi, et al.
Frontiers in Immunology|August 2, 2021
Mechanosensation and Mechanotransduction in Natural Killer CellsGiorgio Santoni, Consuelo Amantini, Matteo Santoni, et al.
Advances in Experimental Medicine and Biology|October 25, 2019
Targeting Transient Receptor Potential Channels by MicroRNAs Drives Tumor Development and ProgressionGiorgio Santoni, Maria Beatrice Morelli, Matteo Santoni, et al.
Current Drug Targets|December 4, 2014
Morphologic and molecular backgrounds for personalized management of genito-urinary cancers: an overviewRodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, et al.
Advances in Experimental Medicine and Biology|October 25, 2019
Calcium Signaling and the Regulation of Chemosensitivity in Cancer Cells: Role of the Transient Receptor Potential ChannelsGiorgio Santoni, Maria Beatrice Morelli, Oliviero Marinelli, et al.
Pageof 46